Advertisement

Topics

Active Biotech AB (publ) Company Profile

22:26 EDT 20th June 2018 | BioPortfolio

The Active Biotech of today originated from a research project at Pharmacia now known as the TTS project. In 1991, Pharmacia set up a new research facility in Lund to focus on this work. When Pharmacia merged with Upjohn in 1997, the Lund department was threatened with closure. This was when Active Biotech bought both the facility and the operations, including the 165 or so researchers. The research portfolio included both the TTS and the SAIK projects. By 1996, Active Biotech had also bought SBL Vaccin from the Swedish State. This part of its operations was later sold to UK company PowderJect Pharmaceuticals in 2001. Active Biotech was founded by Bo Håkansson, who left the business in 2000.

Location

Box 724
Lund
SE-220 07
Sweden

Contact

Phone: 46 46 19 20 00
Fax: 46 46 19 20 50
Email: info@activebiotech.com


News Articles [2067 Associated News Articles listed on BioPortfolio]

Annual Report 2017 Active Biotech AB (publ)

    PRESS RELEASE Active Biotech's Annual Report 2017 is now available för download at www.activebiotech.com. The Annual Report will only be digitally distributed. The Engl...

NASDAQ OMX Nordic: Derivatives: Adjustment in Active Biotech due to rights issue (02/18)

Extraordinary General Meeting (EGM) of Active Biotech AB (Active Biotech) held on March 19, 2018, approved a rights issue whereby shareholders are entitled to one (1) new share for every two (2) sh...

Annual General Meeting of Active Biotech AB

PRESS RELEASE The Annual General Meeting of Active Biotech was held on May 17, 2018. In accordance with the Board of Directors' proposal, it was resolved that no dividend would...

Active Biotech carries out rights issue

  Read the press release here Active Biotech carries out rights issueThis announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.The iss...

NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING

The shareholders of Active Biotech AB (publ) are invited to the Extraordinary Shareholders' Meeting to be held on Monday 19 March 2018, at 5 pm at the company's offices, Scheelev...

Active-Investors: Research Reports on Oncolytics Biotech, Aurinia Pharma, Immunovaccine, and IntelliPharmaCeutics

LONDON, UK / ACCESSWIRE / February 12, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: Oncolytics Biotech, Aur...

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares in Active Biotech AB (38/18)

With effect from March 28, 2018, the subscription rights in Active Biotech AB will be quoted on the list for Equity rights. Quotation will continue up until and including April 9, 2018. Instrument:...

Active Biotech's partner NeoTX presents new data at AACR demonstrating that ANYARA enhances the efficacy of checkpoint blockade in preclinical models of cancer

PRESS RELEASE   Lund, April 12, 2018 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announces that its partner NeoTX Therapeutics Ltd. will present new data for ANYARA (Naptumumab E...

Drugs and Medications [10 Associated Drugs and Medications listed on BioPortfolio]

Ocufresh [Taiwan Biotech Co, Ltd]

Minidrops [Taiwan Biotech Co, Ltd]

Iman time control all day moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Iman time control oil free moisture complex spf 15 [Sheencolor Biotech Co., Ltd.]

Drug Fact

Stelara [Janssen Biotech, Inc.]

These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) Injection, for subcutaneous useIn...

PubMed Articles [773 Associated PubMed Articles listed on BioPortfolio]

Biotech Crop Planting Resumes High Adoption in 2016.

The global area of biotech crops in 2016 increased from 179.7 million hectares to 185.1 million hectares, a 3% increase equivalent to 5.4 million hectares. Some 26 countries planted biotech crops, 19 ...

Just how good an investment is the biopharmaceutical sector?

Uncertainty surrounding the risk and reward of investments in biopharmaceutical companies poses a challenge to those interested in funding such enterprises. Using data on publicly traded stocks, we tr...

Third-quarter biotech job picture.

Research biotech patenting 2017.

Resting Autonomic Function in Active and Insufficiently Active People Living with HIV.

Autonomic dysfunction appears to be prevalent in people living with HIV/AIDS (PLWHA). However, there are limited data on the resting autonomic responses to exercise in active and insufficiently active...

Clinical Trials [2292 Associated Clinical Trials listed on BioPortfolio]

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in h...

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Pevion Biotech has designed a therapeutic vaccine to treat patients who suffer from chronic hepatitis C virus infection. The vaccine is based on a combination of the PeviPRO and PeviTER pl...

The Effect of Selected Fibres and Flours in Flat Bread on Post-prandial Blood Glucose Responses

Identify one or more flat bread mixes that produce a reduction in positive incremental area under the curve (iAUC) of post-prandial glucose relative to the control product.

Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) Vaccine

The purpose of this study is to evaluate the 5-year Immune Persistence of Inactivated Enterovirus Type 71 (EV71) Vaccine manufactured by Sinovac (Beijing) Biotech Co., Ltd.

Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream

Welichem Biotech has developed a small molecule drug candidate, WBI-1001, that selectively targets the pathogenic features of inflammatory skin diseases, including atopic dermatitis (a for...

Companies [1700 Associated Companies listed on BioPortfolio]

Active Biotech AB (publ)

The Active Biotech of today originated from a research project at Pharmacia now known as the TTS project. In 1991, Pharmacia set up a new research facility in Lund to focus on this work. When Pharmaci...

Active Biotech

Active Biotech AB is a Swedish biotechnology company focused on the research and development of pharmaceuticals and vaccines. Their core competence is knowledge of the human immune system.

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

ECI Biotech

ECI Biotech is an early stage protein sensor company with strong intellectual property of particular value for diagnostic sensors and therapeutics. Founded in 1998, its technologies relate to the dete...

Swedish Orphan Biovitrum AB (publ)

More Information about "Active Biotech AB (publ)" on BioPortfolio

We have published hundreds of Active Biotech AB (publ) news stories on BioPortfolio along with dozens of Active Biotech AB (publ) Clinical Trials and PubMed Articles about Active Biotech AB (publ) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Active Biotech AB (publ) Companies in our database. You can also find out about relevant Active Biotech AB (publ) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record